Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Apr;64(4):1181–1189. doi: 10.1128/iai.64.4.1181-1189.1996

Toxoplasma gondii-induced immune suppression by human peripheral blood monocytes: role of gamma interferon.

J Y Channon 1, L H Kasper 1
PMCID: PMC173901  PMID: 8606076

Abstract

The ability of Toxoplasma gondii to evade the host immune response during primary infection in humans is poorly understood. In murine toxoplasmosis, infected spleen macrophages release soluble factors that mediate a transient immunosuppression, which may allow the parasite to become established. When an enriched population of human monocytes from seronegative individuals was incubated with toxoplasmas in vitro, soluble factors that mediated market suppression of mitogen-induced lymphocyte DNA synthesis were released. Irradiated tachyzoites that do not undergo replication were sufficient stimuli for near-maximal soluble factor release. Up to 50% of the soluble factor-mediated suppression is attributable to a gamma interferon (IFN-gamma)-dependent pathway, and the mediator of the remaining inhibition is neither interleukin-10, transforming growth factor beta, prostaglandin E2, lipoxygenase products, nitric oxide, nor tumor necrosis factor alpha-induced mitochondrial cell-derived reactive oxygen intermediates. IFN-gamma also mediates the up-regulation of an antigen-presenting cell phenotype by both infected and uninfected macrophages. However, IFN-gamma does not activate macrophages to become toxoplasmacidal; instead, intracellular toxoplasmas replicate and reinfect, eventually lysing the macrophage population. These results suggest that T. gondii is able to evade the naive host immune response by induction of soluble immunosuppressive factors that allow the parasite to become established during an acute infection.

Full Text

The Full Text of this article is available as a PDF (310.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albina J. E., Abate J. A., Henry W. L., Jr Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J Immunol. 1991 Jul 1;147(1):144–148. [PubMed] [Google Scholar]
  2. Anderson S. E., Jr, Krahenbuhl J. L., Remington J. S. Longitudinal studies of lymphocyte response to Toxoplasma antigen in humans infected with T. gondii. J Clin Lab Immunol. 1979 Nov;2(4):293–297. [PubMed] [Google Scholar]
  3. Barton C. H., Whitehead S. H., Blackwell J. M. Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol Med. 1995 Mar;1(3):267–279. [PMC free article] [PubMed] [Google Scholar]
  4. Bukrinsky M. I., Nottet H. S., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Gendelman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med. 1995 Feb 1;181(2):735–745. doi: 10.1084/jem.181.2.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Candolfi E., Hunter C. A., Remington J. S. Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect Immun. 1994 May;62(5):1995–2001. doi: 10.1128/iai.62.5.1995-2001.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Candolfi E., Hunter C. A., Remington J. S. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect Immun. 1995 Mar;63(3):751–756. doi: 10.1128/iai.63.3.751-756.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Channon J. Y., Kasper L. H. Parasite subversion of the host cell endocytic network. Parasitol Today. 1995 Feb;11(2):47–48. doi: 10.1016/0169-4758(95)80113-8. [DOI] [PubMed] [Google Scholar]
  8. Darji A., Sileghem M., Heremans H., Brys L., De Baetselier P. Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon. Infect Immun. 1993 Jul;61(7):3098–3102. doi: 10.1128/iai.61.7.3098-3102.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fadul C. E., Channon J. Y., Kasper L. H. Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes. Infect Immun. 1995 Nov;63(11):4290–4294. doi: 10.1128/iai.63.11.4290-4294.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Furtado G. C., Slowik M., Kleinman H. K., Joiner K. A. Laminin enhances binding of Toxoplasma gondii tachyzoites to J774 murine macrophage cells. Infect Immun. 1992 Jun;60(6):2337–2342. doi: 10.1128/iai.60.6.2337-2342.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gazzinelli R. T., Hieny S., Wynn T. A., Wolf S., Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6115–6119. doi: 10.1073/pnas.90.13.6115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Graziano R. F., Fanger M. W. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J Immunol. 1987 Nov 15;139(10):3536–3541. [PubMed] [Google Scholar]
  13. Graziano R. F., Fanger M. W. Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface. J Immunol. 1987 Feb 1;138(3):945–950. [PubMed] [Google Scholar]
  14. Haque S., Khan I., Haque A., Kasper L. Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated inhibitory effects. Infect Immun. 1994 Jul;62(7):2908–2916. doi: 10.1128/iai.62.7.2908-2916.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Joiner K. A., Fuhrman S. A., Miettinen H. M., Kasper L. H., Mellman I. Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science. 1990 Aug 10;249(4969):641–646. doi: 10.1126/science.2200126. [DOI] [PubMed] [Google Scholar]
  16. Jones T. C., Alkan S., Erb P. Spleen and lymph node cell populations, in vitro cell proliferation and interferon-gamma production during the primary immune response to Toxoplasma gondii. Parasite Immunol. 1986 Nov;8(6):619–629. doi: 10.1111/j.1365-3024.1986.tb00875.x. [DOI] [PubMed] [Google Scholar]
  17. Kasper L. H., Crabb J. H., Pfefferkorn E. R. Isolation and characterization of a monoclonal antibody-resistant antigenic mutant of Toxoplasma gondii. J Immunol. 1982 Oct;129(4):1694–1699. [PubMed] [Google Scholar]
  18. Kasper L. H. Isolation and characterization of a monoclonal anti-P30 antibody resistant mutant of Toxoplasma gondii. Parasite Immunol. 1987 Jul;9(4):433–445. doi: 10.1111/j.1365-3024.1987.tb00521.x. [DOI] [PubMed] [Google Scholar]
  19. Khan I. A., Matsuura T., Kasper L. H. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol. 1995 Apr;17(4):185–195. doi: 10.1111/j.1365-3024.1995.tb00888.x. [DOI] [PubMed] [Google Scholar]
  20. Luft B. J., Kansas G., Engleman E. G., Remington J. S. Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. J Infect Dis. 1984 Nov;150(5):761–767. doi: 10.1093/infdis/150.5.761. [DOI] [PubMed] [Google Scholar]
  21. Markert M., Carnal B., Mauël J. Nitric oxide production by activated human neutrophils exposed to sodium azide and hydroxylamine: the role of oxygen radicals. Biochem Biophys Res Commun. 1994 Mar 30;199(3):1245–1249. doi: 10.1006/bbrc.1994.1364. [DOI] [PubMed] [Google Scholar]
  22. McLeod R., Beem M. O., Estes R. G. Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis. J Clin Lab Immunol. 1985 Jul;17(3):149–153. [PubMed] [Google Scholar]
  23. McLeod R., Estes R., Mack D. G., McLeod E. G. Effects of human alveolar macrophages and peripheral blood monocytes on Toxoplasma gondii. J Infect Dis. 1983 May;147(5):957–957. doi: 10.1093/infdis/147.5.957. [DOI] [PubMed] [Google Scholar]
  24. Mills C. D. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol. 1991 Apr 15;146(8):2719–2723. [PubMed] [Google Scholar]
  25. Morisaki J. H., Heuser J. E., Sibley L. D. Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J Cell Sci. 1995 Jun;108(Pt 6):2457–2464. doi: 10.1242/jcs.108.6.2457. [DOI] [PubMed] [Google Scholar]
  26. Murray H. W., Teitelbaum R. F. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis. 1992 Mar;165(3):513–517. doi: 10.1093/infdis/165.3.513. [DOI] [PubMed] [Google Scholar]
  27. Pfefferkorn E. R., Pfefferkorn L. C. Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutants. Exp Parasitol. 1976 Jun;39(3):365–376. doi: 10.1016/0014-4894(76)90040-0. [DOI] [PubMed] [Google Scholar]
  28. Schleifer K. W., Mansfield J. M. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol. 1993 Nov 15;151(10):5492–5503. [PubMed] [Google Scholar]
  29. Schneemann M., Schoedon G., Hofer S., Blau N., Guerrero L., Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis. 1993 Jun;167(6):1358–1363. doi: 10.1093/infdis/167.6.1358. [DOI] [PubMed] [Google Scholar]
  30. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 1993 Aug;12(8):3095–3104. doi: 10.1002/j.1460-2075.1993.tb05978.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sher A., Oswald I. P., Hieny S., Gazzinelli R. T. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. J Immunol. 1993 May 1;150(9):3982–3989. [PubMed] [Google Scholar]
  32. Sibley L. D., Weidner E., Krahenbuhl J. L. Phagosome acidification blocked by intracellular Toxoplasma gondii. 1985 May 30-Jun 5Nature. 315(6018):416–419. doi: 10.1038/315416a0. [DOI] [PubMed] [Google Scholar]
  33. Strickland G. T., Ahmed A., Sell K. W. Blastogenic response of Toxoplasma-infected mouse spleen cells to T- and B-cell mitogens. Clin Exp Immunol. 1975 Oct;22(1):167–176. [PMC free article] [PubMed] [Google Scholar]
  34. Suzuki Y., Joh K., Kobayashi A. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. III. Suppression of antibody responses to parasite itself. Cell Immunol. 1987 Dec;110(2):218–225. doi: 10.1016/0008-8749(87)90117-1. [DOI] [PubMed] [Google Scholar]
  35. Wilson C. B., Remington J. S. Activity of human blood leukocytes against Toxoplasma gondii. J Infect Dis. 1979 Dec;140(6):890–895. doi: 10.1093/infdis/140.6.890. [DOI] [PubMed] [Google Scholar]
  36. al-Ramadi B. K., Meissler J. J., Jr, Huang D., Eisenstein T. K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol. 1992 Sep;22(9):2249–2254. doi: 10.1002/eji.1830220911. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES